Cancers’ sweet tooth may be weakness
(Emory University) Cancer cells tend to take up more glucose than healthy cells and metabolize it in a process called glycolysis. An enzyme called PKM2 that governs cancer cells’ preference for glucose may be a valuable anti-cancer drug target.
source : www.eurekalert.org
Related News:
- Road Mapping Could Be Key To Curing TB
- Even Normal Glucose in Kids Could Predict Diabetes Later (CME/CE)
- Mechanical Forces Could Affect Gene Expression
- Placental Infection Could Spur Asthma (CME/CE, with audio)
- Early Intervention Could Prevent Schizophrenia
- Research Breakthrough Could Lead To New Treatment For Malaria
- UCF professor’s vaccine could be lethal weapon against malaria, cholera
- Global supply of rare earth elements could be wiped out by 2012
- Surprising Discovery Could Help Scientists Refine Treatment For Advanced Melanoma
- Llama proteins could play a vital role in the war on terror
Details :
Submited at Wednesday, November 18th, 2009 at 1:00 pm on Cancer and Oncology by jessica
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















